KR100698452B1 - Method of preparing ruminant protective choline - Google Patents
Method of preparing ruminant protective choline Download PDFInfo
- Publication number
- KR100698452B1 KR100698452B1 KR1020060039733A KR20060039733A KR100698452B1 KR 100698452 B1 KR100698452 B1 KR 100698452B1 KR 1020060039733 A KR1020060039733 A KR 1020060039733A KR 20060039733 A KR20060039733 A KR 20060039733A KR 100698452 B1 KR100698452 B1 KR 100698452B1
- Authority
- KR
- South Korea
- Prior art keywords
- choline
- melting point
- oil
- protective
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229960001231 choline Drugs 0.000 title claims abstract description 124
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 title claims abstract description 118
- 238000000034 method Methods 0.000 title claims abstract description 53
- 241000282849 Ruminantia Species 0.000 title claims abstract description 34
- 230000001681 protective effect Effects 0.000 title claims abstract description 34
- 238000002844 melting Methods 0.000 claims abstract description 62
- 230000008018 melting Effects 0.000 claims abstract description 62
- 239000003921 oil Substances 0.000 claims abstract description 43
- 239000011248 coating agent Substances 0.000 claims abstract description 41
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 39
- 239000011630 iodine Substances 0.000 claims abstract description 39
- 238000000576 coating method Methods 0.000 claims abstract description 38
- 210000004767 rumen Anatomy 0.000 claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 claims abstract description 30
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 27
- 239000000194 fatty acid Substances 0.000 claims abstract description 27
- 229930195729 fatty acid Natural products 0.000 claims abstract description 27
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 26
- 238000002156 mixing Methods 0.000 claims abstract description 21
- 230000008569 process Effects 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000005538 encapsulation Methods 0.000 claims abstract description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 239000011230 binding agent Substances 0.000 claims abstract description 6
- 229920002472 Starch Polymers 0.000 claims abstract description 5
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 5
- 229920002678 cellulose Polymers 0.000 claims abstract description 5
- 239000001913 cellulose Substances 0.000 claims abstract description 5
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 5
- 239000008107 starch Substances 0.000 claims abstract description 5
- 235000019698 starch Nutrition 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 5
- 239000010457 zeolite Substances 0.000 claims abstract description 5
- 235000019198 oils Nutrition 0.000 claims description 41
- 239000000203 mixture Substances 0.000 claims description 22
- -1 choline compound Chemical class 0.000 claims description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- 239000000344 soap Substances 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 4
- 235000019482 Palm oil Nutrition 0.000 claims description 3
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 235000019486 Sunflower oil Nutrition 0.000 claims description 3
- 239000002285 corn oil Substances 0.000 claims description 3
- 235000005687 corn oil Nutrition 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 239000003346 palm kernel oil Substances 0.000 claims description 3
- 235000019865 palm kernel oil Nutrition 0.000 claims description 3
- 239000002540 palm oil Substances 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 239000002600 sunflower oil Substances 0.000 claims description 3
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 2
- 235000019743 Choline chloride Nutrition 0.000 claims description 2
- 229960003178 choline chloride Drugs 0.000 claims description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 2
- 230000003100 immobilizing effect Effects 0.000 claims description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- RPERJPYDELTDMR-UHFFFAOYSA-K 2-hydroxyethyl(trimethyl)azanium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound C[N+](C)(C)CCO.C[N+](C)(C)CCO.C[N+](C)(C)CCO.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O RPERJPYDELTDMR-UHFFFAOYSA-K 0.000 claims 1
- KZSXRDLXTFEHJM-UHFFFAOYSA-N 5-(trifluoromethyl)benzene-1,3-diamine Chemical compound NC1=CC(N)=CC(C(F)(F)F)=C1 KZSXRDLXTFEHJM-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 235000021314 Palmitic acid Nutrition 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims 1
- 239000008116 calcium stearate Substances 0.000 claims 1
- 235000013539 calcium stearate Nutrition 0.000 claims 1
- 229960004874 choline bitartrate Drugs 0.000 claims 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 claims 1
- 235000012343 cottonseed oil Nutrition 0.000 claims 1
- 239000002385 cottonseed oil Substances 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims 1
- 244000005700 microbiome Species 0.000 abstract description 7
- 230000002209 hydrophobic effect Effects 0.000 abstract description 6
- 239000002245 particle Substances 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000007921 spray Substances 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 239000003507 refrigerant Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 description 47
- 239000002775 capsule Substances 0.000 description 29
- 244000144972 livestock Species 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000009469 supplementation Effects 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 208000004930 Fatty Liver Diseases 0.000 description 3
- 206010019708 Hepatic steatosis Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 208000010706 fatty liver disease Diseases 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 150000003248 quinolines Chemical class 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000004481 Choline Deficiency Diseases 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000021752 choline deficiency disease Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000031142 liver development Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 101710134784 Agnoprotein Proteins 0.000 description 1
- 102000000476 Fatty Acid Transport Proteins Human genes 0.000 description 1
- 108010055870 Fatty Acid Transport Proteins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101001008429 Homo sapiens Nucleobindin-2 Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 102100027441 Nucleobindin-2 Human genes 0.000 description 1
- 206010038460 Renal haemorrhage Diseases 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000021232 nutrient availability Nutrition 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000022676 rumination Effects 0.000 description 1
- 208000015212 rumination disease Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
- A23K40/35—Making capsules specially adapted for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
본 발명은 콜린을 담체에 고정화하여 수분을 제거한 후, 수분이 제거된 입자를 소수성 물질로 1차 캡슐화시키고, 이 캡슐화된 입자를 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃ 이상인 지방산 단독 또는 그들의 둘 이상 조합한 것을 사용하여 2차 캡슐화하여 반추위 내에서 반추위 미생물로부터 보호될 수 있도록 한 반추위 보호 콜린의 제조방법에 관한 것이다.The present invention immobilizes choline on a carrier to remove water, and then, first, encapsulates the water-removed particles with a hydrophobic substance, and the encapsulated particles have an iodine value of 1.0 or lower and a melting point of 57 ° C. or higher and a melting point of 40 ° C. or higher. The present invention relates to a method for preparing ruminant protective choline, which is encapsulated by ruminant microorganisms in the rumen by encapsulating the fatty acid alone or in combination of two or more thereof.
상기의 본 발명은,The present invention described above,
농축 액상 콜린을 실리카, 셀룰로오즈, 전분, 제올라이트 등의 담체에 고정화 시킨 후 수분을 제거하여 담체에 고정화된 콜린을 제조하는 과정과,Fixing the concentrated liquid choline to a carrier such as silica, cellulose, starch, zeolite, and then removing water to prepare choline immobilized on the carrier,
상기의 고정화된 콜린에 비스왁스, PEG, 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 등의 결합코팅제와 혼합기에서 혼합 교반한 후 압출기를 거처 1차 캡슐화 코팅된 콜린을 제조하는 과정과,Preparing a first encapsulated coated choline through an extruder after mixing and stirring a binder coating agent such as hardening oil having a biswax, PEG, iodine value of 1.0 or less and a melting point of 57 ° C. or higher in a mixer,
상기의 1차 캡슐화된 콜린중 0.5~2.0㎜의 1차 캡슐화된 콜린을 선별하여 하이스피드믹서, 리본믹서, 레디게믹서, 유동층 공정기 등의 2차 캡슐화 기기를 사용하여 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 및 녹는점이 40℃이상인 지방산들을 하나 또는 그들의 둘 이상 조합한 것을 사용하여 2차 캡슐화하는 과정들에 의하여 이중 코팅된 반추위 보호 콜린을 제조하도록 함으로써 거대구멍이 생성될 우려가 없으며 형태가 고르고 균일한 모습을 나타내는 장점이 있고, 2차 코팅과정을 거치므로 콜린이 표면에 분포할 가능성이 없어서 투입된 콜린의 대부분이 안정성을 유지할 수 있는 장점이 있으며, 게다가 냉동스프레이 방식에서 사용하는 냉매를 사용하지 않아서 제조경비가 적게 들고 부지와 장치비도 적게 드는 장점이 있어서 제품의 생산단가를 낮출 수 있도록 구성함을 특징으로 한다.The primary encapsulated choline of 0.5 ~ 2.0mm of the primary encapsulated choline is selected and the iodine value is 1.0 or less by using a second encapsulation device such as a high speed mixer, ribbon mixer, reggae mixer, fluidized bed process machine, etc. There is no fear that macropores are produced by preparing double coated rumen protective choline by secondary encapsulation process using a cured oil having a melting point of 57 ° C. or higher and one or a combination of two or more fatty acids having a melting point of 40 ° C. or higher. It has the advantage of showing uniform shape and uniformity, and because it goes through the second coating process, there is no possibility that choline is distributed on the surface, so most of the added choline can maintain stability, and it is a refrigerant used in the frozen spray method. The production cost of the product is low because there is less manufacturing cost and less site and equipment cost Characterized in that it can be configured to lower the value.
Description
본 발명은 반추위 보호 콜린의 제조방법에 관한 것으로, 상세하게는 콜린을 담체에 고정화하여 수분을 제거한 후, 수분이 제거된 입자를 소수성 물질로 1차 캡슐화시키고, 이 캡슐화된 입자를 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃ 이상인 지방산 단독 또는 그들의 둘 이상 조합한 것을 사용하여 2차 캡슐화하여 반추위 내에서 반추위 미생물로부터 보호될 수 있도록 한 반추위 보호 콜린의 제조방법에 관한 것이다.The present invention relates to a method for preparing ruminant protective choline, and in detail, the choline is immobilized on a carrier to remove water, and then, the particles from which water is removed are first encapsulated with a hydrophobic substance, and the encapsulated particles are iodine value 1.0. The present invention relates to a method for producing ruminant protective choline, which can be protected from rumen microorganisms in the rumen by encapsulating the cured oil having a melting point of 57 ° C. or higher or a fatty acid having a melting point of 40 ° C. or higher alone or a combination of two or more thereof.
비유중인 젖소에 대한 콜린 요구량은 아직 밝혀져 있지 않으며, 일부 가축에 대한 연구에서 필수성분으로서 알려져 있지만 반추동물의 반추위내에서 대부분의 콜린이 분해되기 때문에 반추위를 통과하여 소장에서 흡수되어 이용될 수 있도록 반추위 보호기술 개발이 필요하다.Choline requirements for lactating cows are not yet known and are known as an essential ingredient in some livestock studies, but because most of the choline is broken down in the rumen of ruminants, it can be absorbed and used in the small intestine through the rumen. Development of protection technology is necessary.
콜린에 대한 비유반응은 필수 아미노산인 메티오닌의 반응과 비슷하며, 결핍시 대표 증상으로 근육약화와 지방간의 발생, 신장출혈 등으로 나타난다.The analogy to choline is similar to that of the essential amino acid methionine, which is a sign of deficiency, including muscle weakness, fatty liver development, and renal hemorrhage.
콜린을 주입하는 연구에서 착유 젖소에서 콜린이 제한 영양소라는 것이 확인 되었으며, 콜린 결핍시 나타나는 지방간의 발생은 가축이 콜린 결핍사료를 섭취하였을 경우에 수일 내로 발생하였는데, 이러한 것은 간의 지방대사와 분비의 기전의 이상에 기인하며, 콜린을 증가시킴으로서 지방산 이동이 증가하였고, 지방간의 발생을 낮추는 효과가 있었다.Studies with choline infusion confirmed that choline was a limiting nutrient in milking cows. Fatty liver development during choline deficiency occurred within a few days when cattle were fed choline deficiency feed, a mechanism of liver fat metabolism and secretion. Due to the abnormality of, and increased choline fatty acid transport was increased, it was effective in reducing the occurrence of fatty liver.
콜린 보충은 blood glucose, plasma cholesterol, serum insulin과 serum NEFA(nonesterified fatty acids)에 영향을 미치는 것으로 보고되고 있으며, 콜린의 보충이 우유생산, 우유 성분, 증체율과 도체특성 개선에 영향을 주지만 사료로 보충된 콜린 염화물(choline chloride)이 반추위 내에서 많은 부분이 분해되어 진다고 보고되었다.Choline supplementation has been reported to affect blood glucose, plasma cholesterol, serum insulin and serum NEFAs (choline supplementation). Choline supplementation affects milk production, milk composition, weight gain and carcass characteristics but is supplemented with feed. It has been reported that choline chloride breaks down much of the rumen.
반추위 미생물은 사료 중의 phosphatidyl choline을 choline과 phosphodiglycerides로 분해한다고 보고되고 있으며, 반추 미생물은 유리된 콜린과 이용할 수 있는 콜린을 중간 대사물질인 trimethylamine을 거쳐 메탄으로 전변시키며, 콜린은 반추위 프로토조아에 의하여 phosphatidyl-choline의 합성에 이용되고, 사료중 콜린의 1% 미만이 소장에 도달한다고 보고되었다.Ruminant microorganisms have been reported to break down phosphatidyl choline from feed into choline and phosphodiglycerides. Ruminant microorganisms convert free choline and available choline to methane via an intermediate metabolite, trimethylamine, and choline is phosphatidyl by rumen protozoa. It has been reported that less than 1% of choline in the feed reaches the small intestine, which is used for the synthesis of -choline.
이러한 이유로 반추동물에게도 공급할 수 있는 반추위 분해에 안정한 코팅된 콜린화합물이 필요하게 됨을 인식하게 되었다.For this reason, it was recognized that there is a need for coated choline compounds that are stable to ruminant degradation, which can also be supplied to ruminants.
콜린은 가축용 동물에게는 필수적인 영양성분이나 반추동물에게는 반추위에서 분해되어 그 효능을 볼 수 없는 이유로 오래전부터 콜린성분이 반추위에서 분해되지 않도록 극복하는 기술이 고안되어 왔다.Choline has been devised to overcome the choline component from rumination for a long time because it is essential nutrients for livestock animals, but ruminants are not resolved in rumen.
예를 들어 미국특허 5.807.594에는 반추동물의 체중을 증가시킬 목적으로 콜 린화합물을 제공하도록 되어 있으나 캡슐화제로 사용하는 원료물질이 다양하게 언급되어 있어서 실제 제품으로 적용시키기에는 비용이 많이 소요될 것으로 보인다.For example, U.S. Patent 5.807.594 provides a choline compound for the purpose of increasing the weight of ruminants. However, various raw materials used as encapsulating agents are mentioned. .
미국특허 5.496.571에는 수유젖소에게 캡슐화된 콜린화합물을 먹이는 것이 공지되어 있고, 미국특허 5.190.775에는 콜린과 같은 생리활성물질을 소수성 코팅을 통해 공급하면 반추위에서 분해 되는 것을 막을 수 있다고 언급되어 있으나 구체적인 제조방법에 대해서는 언급되어 있지 않으며 단순히 소수성 물질로 코팅 또는 캡슐화만으로는 반추위내에서 반추위 미생물에 의한 활성물질의 분해에 대해 완전히 보호하는 데에는 한계가 있는 단점이 있다.U.S. Patent 5.496.571 is known to feed the encapsulated choline compounds to lactating cows, while U.S. Patent 5.190.775 states that feeding bioactive substances such as choline through hydrophobic coatings can prevent degradation in the rumen. There is no mention of a specific manufacturing method and there is a limit to the complete protection against degradation of the active substance by rumen microorganisms in the rumen by simply coating or encapsulating with a hydrophobic substance.
세계특허 WO 94/15480에는 반추동물에게 우유생산량을 증가시키기 위해 콜린화합물을 캡슐화해서 공급하는 것에 대해 언급되어 있으나 이것도 마찬가지로 소수성 코팅을 사용하고 그 제조방법에 대해서는 구체적으로 언급되어 있지 않다.World patent WO 94/15480 mentions the encapsulation of choline compounds in ruminants to increase milk yield, but this also likewise uses hydrophobic coatings and is not specifically mentioned for their preparation.
세계특허 WO 96/08168에는 액상 콜린화합물을 고정화시켜서 지방산이나 지방산염으로 코팅해서 제조하는 것에 대해 언급되어 있으나 사용하는 것이 액상콜린이고 사용된 코팅제인 지방산염인 경우 공기 중의 이산화탄소와 반응을 하는 등의 단점이 있다.World Patent WO 96/08168 mentions the preparation of a liquid choline compound by immobilizing a liquid choline compound and coating it with fatty acids or fatty acid salts. There are disadvantages.
그 외에 WO 03/059088 A1에는 반추위에서 안정할 수 있도록 지질코팅을 하고 있고, US 2005/0019413 A1에는 이중코팅을 언급하고 있으나 복잡한 과정에 의한 방법을 제시하고 있다. In addition, WO 03/059088 A1 is coated with lipids so as to be stable in the rumen, and US 2005/0019413 A1 mentions double coating, but suggests a complicated process.
그 외에도 콜린화합물을 체중증가와 우유생산량 증가를 목적으로 하는 특허들이 많이 출원되어 있고 대부분 공통적으로 반추위에서 콜린이 분해되지 않도록 특정한 보호물질로 코팅해서 사용하는 것을 언급하고 있지만, 그 제조 방법에 대해서는 명시되어 있지 않다.In addition, many patents have been applied for the purpose of gaining weight and increasing milk production, and most commonly refer to the coating of a specific protective material to prevent the breakdown of choline in the rumen. It is not.
또한, 현재 상용화 되어 있는 반추위 보호 콜린의 경우 콜린을 보호물질과 섞어 냉동스프레이 하는 방식의 제품이 있으나 이 경우 부지 및 장치비 소요가 많으며, 사용되는 냉풍의 온도가 영하 60℃의 매우 차가운 공기를 사용함으로써 제품 생산 비용이 증가하게 된다.In addition, the commercially available ruminant protective choline, there is a product of the method of refrigeration spray by mixing the choline with the protective material, but in this case, the site and equipment costs are high, and by using the very cold air of the temperature of the cold wind used is minus 60 ℃ Product production costs will increase.
또한 제품을 순간적인 냉각에 의한 방법으로 생산하기 때문에 제품 내에 거대한 구멍(macro pore)이 형성될 가능성이 있으며 제품 생산 시 운전 조건이 까다롭다. 또한, 제조된 반추위 보호 콜린의 표면에 배열된 콜린에 대해서는 보호하지 못하기 때문에 그 효과가 떨어지는 단점이 있었다.In addition, because the product is produced by instant cooling, there is a possibility of forming macro pores in the product, and the operating conditions are difficult during production. In addition, the choline arranged on the surface of the prepared rumen protective choline can not protect because there was a disadvantage that the effect is inferior.
이에 본 발명은 상기한 바와 같은 종래의 문제점을 해소시키기 위하여 안출된 것으로, 콜린을 담체에 고정화하여 수분을 제거한 후, 수분이 제거된 입자를 소수성 물질로 1차 캡슐화시키고, 이 캡슐화된 입자를 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 단독 또는 그들의 둘 이상 조합한 것을 사용하여 2차 캡슐화하여 반추위 내에서 반추위 미생물로부터 보호될 수 있도록 한 반추위 보호 콜린의 제조방법을 제공하는 것을 그 목적으로 한다.Accordingly, the present invention has been made in order to solve the conventional problems as described above, after fixing the choline to the carrier to remove the water, the water is first encapsulated with a hydrophobic material, the encapsulated particles iodine A method for preparing ruminant protective choline, which is encapsulated using a cured oil having a value of 1.0 or less and a melting point of 57 ° C. or higher, or a fatty acid having a melting point of 40 ° C. or higher alone, or a combination of two or more thereof, to be protected from rumen microorganisms in the rumen. Its purpose is to provide.
상기 목적을 달성하기 위한 본 발명의 반추위 보호 콜린의 제조방법은,Method for producing the rumen protective choline of the present invention for achieving the above object,
농축 액상 콜린을 실리카, 셀룰로오즈, 전분, 제올라이트 등의 담체에 고정화 시킨 후 수분을 제거하여 담체에 고정화된 콜린을 제조하는 과정과,Fixing the concentrated liquid choline to a carrier such as silica, cellulose, starch, zeolite, and then removing water to prepare choline immobilized on the carrier,
상기의 고정화된 콜린에 비스왁스, PEG, 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 등의 결합코팅제와 혼합기에서 혼합 교반한 후 압출기를 거처 1차 캡슐화 코팅된 콜린을 제조하는 과정과,Preparing a first encapsulated coated choline through an extruder after mixing and stirring a binder coating agent such as hardening oil having a biswax, PEG, iodine value of 1.0 or less and a melting point of 57 ° C. or higher in a mixer,
상기의 1차 캡슐화된 콜린중 0.5~2.0㎜의 1차 캡슐화된 콜린을 선별하여 하이스피드믹서, 리본믹서, 레디게믹서, 유동층 공정기 등의 2차 캡슐화 기기를 사용하여 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 및 녹는점이 40℃이상인 지방산들을 하나 또는 그들의 둘 이상 조합한 것을 사용하여 2차 캡슐화하는 과정들에 의하여 이중 코팅된 반추위 보호 콜린을 제조하도록 함으로써 상용화된 냉동스프레이 방식의 제품에서 단점으로 지적되었던 거대구멍이 생성될 우려가 없으며 형태가 고르고 균일한 모습을 나타내는 장점이 있고, 또한 냉동스프레이 방식으로 제조된 제품의 경우 입자 표면에 위치한 콜린의 경우에는 반추위에서 안정성이 떨어지는 단점이 있는 것에 비해 콜린을 함유한 1차 코팅제품에 추가로 2차 코팅과정을 거치므로 콜린이 표면에 분포할 가능성이 없어서 투입된 콜린의 대부분이 안정성을 유지할 수 있는 장점이 있으며, 게다가 냉동스프레이 방식에서 사용하는 냉매를 사용하지 않아서 제조경비가 적게 들고 부지와 장치비도 적게 드는 장점이 있어서 제품의 생산단가를 낮출 수 있다.The primary encapsulated choline of 0.5 ~ 2.0mm of the primary encapsulated choline is selected and the iodine value is 1.0 or less by using a second encapsulation device such as a high speed mixer, ribbon mixer, reggae mixer, fluidized bed process machine, etc. In the frozen-sprayed products commercialized by preparing double-coated ruminant protective choline by secondary encapsulation process using a cured oil having a melting point of 57 ° C. or higher and a fatty acid having a melting point of 40 ° C. or higher of one or a combination of two or more thereof. There is no risk of the formation of macropores, which have been pointed out as a disadvantage, and it has the advantage of having a uniform and uniform shape, and in the case of the product made by the frozen spray method, the choline located on the particle surface has the disadvantage of inferior stability in the rumen. Compared to the first coating product containing choline, the second coating process Since most of the choline added is not likely to be distributed on cotton, it has the advantage of maintaining stability, and since it does not use the refrigerant used in the refrigeration spray method, it has the advantage of low manufacturing cost and low site and equipment cost. The unit price can be lowered.
이러한 것 때문에 반추위에서 보호되지 않는 형태로 콜린을 급여하는 것은 효과가 적고, 낭비가 되는 현상이 발생하게 된다. 따라서, 반추위 보호 콜린을 개발하여 가축사양에 이용함으로서 반추동물의 영양소 이용효율을 높여 생산성을 증가시키고, 축산물내 이행을 증가시켜 기능성 축산물을 생산할 수 있는 사료 첨가제를 개발하도록 한 것이다.Because of this, feeding choline in an unprotected form in the rumen is less effective and wasteful. Therefore, by developing the ruminant protective choline to use in livestock specification to improve the nutrient utilization efficiency of ruminants to increase productivity, to increase the transition in livestock products to develop a feed additive that can produce functional livestock products.
이하, 첨부된 도면을 참조하여 본 발명의 바람직한 실시예를 설명하면 다음과 같다.Hereinafter, exemplary embodiments of the present invention will be described with reference to the accompanying drawings.
(실시예 1)(Example 1)
농축 액상 콜린을 실리카, 셀룰로오즈, 전분, 제올라이트 등의 담체에 고정화 시킨 후 수분을 제거하여 담체에 고정화된 콜린을 제조하는 과정과,Fixing the concentrated liquid choline to a carrier such as silica, cellulose, starch, zeolite, and then removing water to prepare choline immobilized on the carrier,
상기의 고정화된 콜린에 비스왁스, PEG, 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 등의 결합코팅제와 리본믹서, 일반 교환기, 호모믹서, V형 혼합기 등의 혼합기에서 혼합 교반한 후, 익스트루더, 플로더 등의 압출기를 거쳐 1차 캡슐화 코팅된 콜린을 제조하는 과정과,After mixing and stirring the above-mentioned immobilized choline in a binder such as biswax, PEG, iodine value of 1.0 or less, and a curing oil having a melting point of 57 ° C. or more, and a mixer such as a ribbon mixer, a general exchanger, a homomixer, and a V-type mixer, Preparing an encapsulated coated choline through an extruder such as a treader or a plotter,
상기의 1차 캡슐화 코팅된 콜린을 제조할 때 익스트루더, 플로더의 압출관 온도가 10℃∼60℃가 되도록 한다.When producing the above-mentioned primary encapsulated coated choline, the extruder, the extruder temperature of the plotter is 10 ℃ to 60 ℃.
상기의 1차 캡슐화된 콜린중 0.5~2.0㎜의 1차 캡슐화된 콜린을 선별하여 하이스피드믹서, 리본믹서, 레디게믹서, 유동층 공정기 등의 2차 캡슐화 기기를 사용하여 경화식물유, 경화옥수수유, 경화면실유, 경화땅콩유, 경화팜커넬유, 경화팜유, 경화팜스테아린유, 경화해바라기유, 경화채종유 등의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 및 녹는점이 40℃이상인 팔미틱산, 스테아린산 등의 지방산들을 하나 또는 그들의 둘 이상 조합한 것을 사용하여 2차 캡슐화하는 과정들에 의하여 이중 코팅된 반추위 보호 콜린을 제조하도록 한다.The primary encapsulated choline of 0.5 ~ 2.0 ㎜ in the primary encapsulated choline is selected by using a second encapsulation device such as a high speed mixer, ribbon mixer, reggae mixer, fluidized bed process machine, hardened vegetable oil, hardened corn oil , Hardened cotton oil, hardened peanut oil, hardened palm kernel oil, hardened palm oil, hardened palm stearin oil, hardened sunflower oil, hardened vegetable oil, etc. The double encapsulated rumen protective choline is prepared by secondary encapsulation processes using one or a combination of two or more fatty acids such as stearic acid.
(실시예 2)(Example 2)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 1kg에 콜린 5kg을 잘 섞은 후 1.0㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,Process of preparing primary capsule material by mixing 5 kg of choline with 1 kg of hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, and injecting it through a 1.0 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 670 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof 670 g by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
(실시예 3)(Example 3)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 1kg에 콜린 5kg을 잘 섞은 후 1.2㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,A process of preparing a primary capsule material by mixing 5 kg of choline with 1 kg of hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher and injecting it through a 1.2 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 670 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof 670 g by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
(실시예 4)(Example 4)
삭제delete
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 670 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof 670 g by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
(실시예 5)(Example 5)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 1kg에 콜린 5kg을 잘 섞은 후 2.0㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,Process of preparing primary capsule material by mixing 5 kg of choline with 1 kg of hardened oil having a iodine value of 1.0 or less and melting point of 57 ° C. or higher and injecting it through a 2.0 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 670 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof 670 g by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
(실시예 6)(Example 6)
1가 비누 1kg에 콜린 5kg을 잘 섞은 후 2.0㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,Mixing 1 kg of monovalent soap with 5 kg of choline and injecting it through a 2.0 mm porous plate to prepare a primary capsule material,
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 670 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof 670 g by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
(실시예 7)(Example 7)
PEG 1kg에 콜린 5kg을 잘 섞은 후 1.0㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,Mixing 1 kg of PEG with 5 kg of choline and injecting it through a 1.0 mm porous plate to prepare a primary capsule material,
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 670 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof 670 g by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
(실시예 8)(Example 8)
트윈80 1kg에 콜린 5kg을 잘 섞은 후 1.0㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,Mixing 1kg of Choline 5kg with 1kg of Tween 80 and injecting it through a 1.0mm porous plate to prepare a primary capsule material,
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 670 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof 670 g by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
(실시예 9)(Example 9)
스판80 1kg에 콜린 5kg을 잘 섞은 후 1.0㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,Mixing 1 kg of Span 80 with 5 kg of Choline and injecting it through a 1.0 mm porous plate to produce a primary capsule material,
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 670 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof 670 g by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
(실시예 10)(Example 10)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 1kg에 콜린 5kg을 잘 섞은 후 1.5㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,Process of preparing primary capsule material by mixing 5 kg of choline with 1 kg of hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, and injecting it through a 1.5 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 500g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or a fatty acid having a melting point of 40 ° C. or higher and a mixture of 500 g and a mixture thereof. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 33.3%이다.The double coating material described above is 33.3% of the total amount.
(실시예 11)(Example 11)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 1kg에 콜린 5kg을 잘 섞은 후 1.2㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,A process of preparing a primary capsule material by mixing 5 kg of choline with 1 kg of hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher and injecting it through a 1.2 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 350g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material into a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 350 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 25.9%이다.The double coating material described above is 25.9% of the total amount.
(실시예 12)(Example 12)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 1kg에 콜린 5kg을 잘 섞은 후 1.2㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,A process of preparing a primary capsule material by mixing 5 kg of choline with 1 kg of hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher and injecting it through a 1.2 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 250g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or a 250 g of fatty acid having a melting point of 40 ° C. or higher and a mixture of 250 g of the mixture thereof. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 20.0%이다.The double coating material described above is 20.0% of the total amount.
(실시예 13)(Example 13)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 1kg에 콜린 5kg을 잘 섞은 후 1.2㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,A process of preparing a primary capsule material by mixing 5 kg of choline with 1 kg of hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher and injecting it through a 1.2 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 150g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1 kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and melting point of 57 ° C. or higher, or 150 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 13.0%이다.The double coating material described above is 13.0% of the total amount.
(실시예 14)(Example 14)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 1kg에 콜린 5kg을 잘 섞은 후 1.0㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,Process of preparing primary capsule material by mixing 5 kg of choline with 1 kg of hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, and injecting it through a 1.0 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 50g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1 kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or a fatty acid having a melting point of 40 ° C. or higher and 50 g of a mixture thereof by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 4.8%이다.The double coating material described above is 4.8% of the total amount.
(실시예 15)(Example 15)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 2kg에 콜린 4kg을 잘 섞은 후 2.0㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,A process of preparing primary capsule material by mixing 4 kg of choline with 2 kg of hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, and injecting it through a 2.0 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1 kg of the prepared primary capsule material is placed in a high speed mixer and double coated by adding 670 g of a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher and a fatty acid having a melting point of 40 ° C. or higher and 670 g of a mixture thereof. Do it.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
(실시예 16)(Example 16)
액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 3kg에 콜린 3kg을 잘 섞은 후 2.0㎜ 다공판을 통하여 사출하여 1차 캡슐물질을 제조하는 과정과,Process of preparing primary capsule material by mixing 3 kg of choline with 3 kg of hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher and injecting it through a 2.0 mm porous plate;
상기의 제조된 1차 캡슐물질 1kg을 하이스피드 믹서에 넣고 액상의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 또는 녹는점이 40℃이상인 지방산 및 그 들의 혼합물 670g을 첨가하여 이중 코팅하는 과정에 의해 제조하도록 한다.1kg of the prepared primary capsule material in a high speed mixer by adding a hardened oil having a iodine value of 1.0 or less and a melting point of 57 ° C. or higher, or 670 g of a fatty acid having a melting point of 40 ° C. or higher and a mixture thereof 670 g by double coating. To manufacture.
위와 같이 설명된 이중 코팅 물질은 총량 대비 40.1%이다.The double coating material described above is 40.1% of the total amount.
상기와 같이 구성한 본 발명의 반추위 보호 콜린의 제조방법은,The method of producing the rumen protective choline of the present invention configured as described above,
농축 액상 콜린을 실리카, 셀룰로오즈, 전분, 제올라이트 등의 담체에 고정화 시킨 후 수분을 제거하여 담체에 고정화된 콜린을 제조하도록 한다.The concentrated liquid choline is immobilized on a carrier such as silica, cellulose, starch, zeolite and the like to remove water to prepare choline immobilized on the carrier.
상기의 고정화된 콜린에 비스왁스, PEG, 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 등의 결합코팅제와 리본믹서, 일반 교환기, 호모믹서, V형 혼합기 등의 혼합기에서 혼합 교반한 후, 익스트루더, 플로더 등의 압출기를 거쳐 1차 캡슐화 코팅된 콜린을 제조하도록 한다.After mixing and stirring the above-mentioned immobilized choline in a binder such as biswax, PEG, iodine value of 1.0 or less, and a curing oil having a melting point of 57 ° C. or more, and a mixer such as a ribbon mixer, a general exchanger, a homomixer, and a V-type mixer, The primary encapsulated coated choline is prepared through an extruder such as a treader, a floater, or the like.
상기의 1차 캡슐화 코팅된 콜린을 제조할 때 익스트루더, 플로더의 압출관 온도가 10℃∼60℃가 되도록 한다.When producing the above-mentioned primary encapsulated coated choline, the extruder, the extruder temperature of the plotter is 10 ℃ to 60 ℃.
상기의 1차 캡슐화된 콜린중 0.5~2.0㎜의 1차 캡슐화된 콜린을 선별하여 하이스피드믹서, 리본믹서, 레디게믹서, 유동층 공정기 등의 2차 캡슐화 기기를 사용하여 경화식물유, 경화옥수수유, 경화면실유, 경화땅콩유, 경화팜커넬유, 경화팜유, 경화팜스테아린유, 경화해바라기유, 경화채종유 등의 요오드가가 1.0 이하이고 녹는점이 57℃ 이상인 경화유 및 녹는점이 40℃이상인 팔미틱산, 스테아린산 등의 지방산들을 하나 또는 그들의 둘 이상 조합한 것을 사용하여 2차 캡슐화하는 과정들에 의하여 이중 코팅된 반추위 보호 콜린을 제조하도록 한다.The primary encapsulated choline of 0.5 ~ 2.0 ㎜ in the primary encapsulated choline is selected by using a second encapsulation device such as a high speed mixer, ribbon mixer, reggae mixer, fluidized bed process machine, hardened vegetable oil, hardened corn oil , Hardened cotton oil, hardened peanut oil, hardened palm kernel oil, hardened palm oil, hardened palm stearin oil, hardened sunflower oil, hardened vegetable oil, etc. The double encapsulated rumen protective choline is prepared by secondary encapsulation processes using one or a combination of two or more fatty acids such as stearic acid.
상기의 실시예에 의하여 제조한 2중 코팅된 콜린에 대하여 반추위 보호처리 방법별 in vitro 손실율을 살펴보면 다음의 표 1에 도시한 것과 같이 낮아짐을 알 수 있게 된다.Looking at the in vitro loss rate according to the rumen protective treatment method for the double coated choline prepared by the above example it can be seen that as shown in Table 1 below.
(표 1)Table 1
또한 본 발명에 의한 반추위 보호 콜린을 반추 동물에 급여한 결과 유성분 및 체세포수 변화를 살펴보면 다음의 표 2에 도시한 것과 같이 유성분은 증가하고, 체세포 수는 현저히 감소함을 알 수 있게 된다.In addition, as a result of feeding the ruminant protective choline according to the present invention to ruminants, the milk component and the somatic cell number change are shown as shown in Table 2 below, and the milk component is increased and the somatic cell number is markedly decreased.
(표 2)Table 2
한편, 보호 콜린을 수분에 대한 안정성을 측정하기 위하여 시험관시험과 생체내 실험을 수행하였다.On the other hand, in vitro tests and in vivo experiments were performed to measure the stability of the protective choline against water.
먼저 시험관내에서 안정성을 측정하기 위해 제조된 반추위 보호 콜린을 시험관에 넣고 증류수를 첨가하여 5% 수용액으로 제조했다. 제조한 수용액을 JEIO TECH MC-11 멀티스터러 수욕조를 사용하여 40℃±0.1℃에서 2시간동안 교반하였다.First, ruminant protective choline prepared for measuring stability in vitro was put in a test tube, and distilled water was added to prepare a 5% aqueous solution. The prepared aqueous solution was stirred at 40 ° C. ± 0.1 ° C. for 2 hours using a JEIO TECH MC-11 multisterer water bath.
Whatman paper NO. 3을 사용하여 필터링하여 고형분만을 취한 후 45℃±0.1℃에서 12시간 이상 건조하여 잔여 수분을 완전히 제거하였다.Whatman paper NO. Filtering was carried out using 3 to take only solids and dried at 45 ° C. ± 0.1 ° C. for at least 12 hours to completely remove residual moisture.
건조된 시료를 SANPLA DRY KEEPER에서 상온으로 냉각한 후 이중 300㎎을 클로로포름과 메탄올이 부피비로 1:1로 섞은 용매에 넣고 완전히 녹인 후 5% K2CrO4용액을 지시약으로 0.1N AgNO3용액을 적정시약으로 하여 콜린의 함량을 측정 하였으며 모든 분석실험에서 3회 반복 측정하였고, 바탕실험을 병행하여 수행하였다.After cooling the dried sample to room temperature in SANPLA DRY KEEPER, 300 mg of the chloroform and methanol in a volume ratio of 1: 1 mixed completely dissolved in 5% K 2 CrO 4 solution with 0.1N AgNO 3 solution as an indicator Choline content was measured as a titration reagent, and repeated measurements were repeated three times in all assays.
그리고 시험관 시험에서 안정성이 우수하고 제품의 크기가 적당하고 콜린의 함량이 높은 제품을 선정하여 생체 내에서 안정성 시험을 실시하였다.In the in vitro test, a product having excellent stability, suitable product size, and high content of choline was selected and tested for stability in vivo.
본 발명은 상기의 실시예에 의하여 한정되는 것은 아니며 반추동물에 급여하기 위하여 반추위 보호기술이 필요한 다양한 성분의 보호를 위하여서도 사용이 가능하다.The present invention is not limited by the above embodiments and may be used for the protection of various components that require rumen protection technology to feed ruminants.
이상에서 상세히 설명한 바와 같이 본 발명에 따른 반추위 보호 콜린의 제조방법에 의하여서는 2단계 코팅과정을 거쳐 이중 코팅시킨 콜린을 제조하는 방법 및 콜린 급여에 의하여, 반추위에서 미생물 및 pH와 수분에 의해 분해되지 않고 안정하게 하부 소화기관으로 이동해서 흡수될 수 있도록 하고, 반추 가축의 사양에 이용함으로써 반추동물의 영양소 이용효율을 높여 생산성을 증가시킬 수 있게 된다.As described in detail above, according to the method of preparing the rumen protective choline according to the present invention, by the method of preparing the double coated choline through the two-stage coating process and the choline supplementation, the rumen is not decomposed by microorganisms, pH, and water. It can be stably moved to the lower digestive tract and absorbed, and can be used for the specification of ruminant livestock to increase the nutrient utilization efficiency of ruminants, thereby increasing productivity.
반추동물의 영양소 이용성을 높이고 기능성 축산물을 생산하기 위하여 콜린을 반추위내에서 보호할 수 있도록 처리하여 반추동물이 체중, 생산성 및 이용 목적에 따라 첨가량을 조절할 수 있도록 한다.In order to increase the nutrient availability of ruminants and to produce functional livestock products, the choline is treated in the rumen to allow the ruminants to adjust the amount according to their weight, productivity and purpose of use.
반추동물에 급여하면 반추위내에서 콜린이 보호되어 효율적으로 콜린을 사료에 첨가하여 이용할 수 있고 생산성 증가에 기여하며, 콜린이 강화된 기능성 축산물을 생산할 수 있다.Feeding ruminants protects choline in the rumen, making it possible to efficiently add choline to feed, contribute to increased productivity, and produce choline-enriched functional livestock.
반추위 보호가 필요한 여러 가지 성분을 보호하는데 응용할 수 있어, 다양하게 적용할 수 있어 새로운 사료첨가제를 생산하는데 이용 가능한 효과가 있다.It can be applied to protect a variety of ingredients that need ruminant protection, and thus can be applied in various ways to produce new feed additives.
Claims (15)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060039733A KR100698452B1 (en) | 2006-05-02 | 2006-05-02 | Method of preparing ruminant protective choline |
| PCT/KR2006/004773 WO2007126191A1 (en) | 2006-05-02 | 2006-11-14 | Method for preparing ruminally protected choline |
| JP2009509394A JP5159766B2 (en) | 2006-05-02 | 2006-11-14 | Method for producing rumen protecting choline |
| CN2006800544697A CN101431903B (en) | 2006-05-02 | 2006-11-14 | Method for preparing ruminally protected choline |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060039733A KR100698452B1 (en) | 2006-05-02 | 2006-05-02 | Method of preparing ruminant protective choline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR100698452B1 true KR100698452B1 (en) | 2007-03-23 |
Family
ID=38655688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020060039733A Active KR100698452B1 (en) | 2006-05-02 | 2006-05-02 | Method of preparing ruminant protective choline |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP5159766B2 (en) |
| KR (1) | KR100698452B1 (en) |
| CN (1) | CN101431903B (en) |
| WO (1) | WO2007126191A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101069118B1 (en) | 2008-10-22 | 2011-09-30 | 경상대학교산학협력단 | Method for preparing enteric choline chloride and choline chloride prepared according to the method |
| KR101219740B1 (en) | 2010-06-07 | 2013-01-11 | 대한민국 | Manufacturing method of Ruminally Protected Choline for high choline milk production And Ruminally Protected Choline Using Thereof |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5399072B2 (en) | 2005-09-12 | 2014-01-29 | アベラ ファーマスーティカルズ インコーポレイテッド | System for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated therewith |
| US8435224B2 (en) | 2005-09-12 | 2013-05-07 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds |
| WO2007033082A2 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
| MX2011011006A (en) * | 2009-04-23 | 2011-11-18 | H J Baker & Bro Inc | Granular feed supplement. |
| CN101897463A (en) * | 2009-06-01 | 2010-12-01 | 王中心 | Method for producing ruminant rumen bypass product |
| EP2493315B1 (en) | 2009-10-30 | 2018-03-28 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (dmso) or dmso and methylsulfonylmethane (msm) formulations to treat infectious diseases |
| CN103549153A (en) * | 2013-11-11 | 2014-02-05 | 张维 | Rumen protected choline chloride particle as well as production method thereof |
| US20160338948A1 (en) | 2014-01-31 | 2016-11-24 | Morishita Jintan Co., Ltd. | Orally administered agent for ruminants and ruminant feed containing same |
| CN104719670B (en) * | 2015-03-24 | 2018-04-27 | 河北碧隆化工科技有限公司 | A kind of high-content ruminant rumen choline chloride particle and preparation method thereof |
| CN104872395B (en) * | 2015-06-05 | 2018-06-19 | 西双版纳华坤生物科技有限责任公司 | A kind of milk and its production method rich in omega-fatty acid and conjugated linoleic acid |
| CN105166413A (en) * | 2015-10-10 | 2015-12-23 | 山西农业大学 | Rumen-bypass riboflavin additive for beef cattle and preparation method of rumen-bypass riboflavin additive |
| EP4035537A4 (en) * | 2019-09-26 | 2023-09-27 | Ajinomoto Co., Inc. | FEED ADDITIVE COMPOSITION FOR RUMINANTS |
| CN112167165B (en) * | 2020-09-29 | 2022-02-11 | 厦门汇盛生物有限公司 | Preparation and application of a compounded rumen polyunsaturated fatty acid powder |
| CN113331306A (en) * | 2021-06-03 | 2021-09-03 | 北京中科万联科技有限公司 | Additive for improving livestock and poultry physiological function based on yucca, and preparation method and application thereof |
| CN117121981A (en) * | 2023-08-29 | 2023-11-28 | 辽宁亚禾营养科技有限责任公司 | Preparation method of rumen protected linolenic acid |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0163831B1 (en) * | 1995-03-18 | 1998-11-16 | 비비바흐, 카르그 | Method for preparing lysine protected against degradation in rumen and animal feed including the same |
| US6797291B2 (en) * | 2002-01-09 | 2004-09-28 | Balchem Corporation | Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4713245A (en) * | 1984-06-04 | 1987-12-15 | Mitsui Toatsu Chemicals, Incorporated | Granule containing physiologically-active substance, method for preparing same and use thereof |
| BR8506634A (en) * | 1984-12-20 | 1986-09-09 | Rhone Poulenc Sante | COMPOSITES FOR COATING FOOD ADDITIVES INTENDED FOR RUMINANTS AND GRANULATES IN THE FORM OF MICROCAPSULES SO COATED |
| CA1331713C (en) * | 1988-12-29 | 1994-08-30 | Hitoshi Iijima | Granular composition for ruminant |
| US5190775A (en) * | 1991-05-29 | 1993-03-02 | Balchem Corporation | Encapsulated bioactive substances |
| WO1994015480A1 (en) * | 1992-12-30 | 1994-07-21 | Morgan Manufacturing Co., Inc. | Composition and method for ruminant milk production |
| JPH06339343A (en) * | 1993-04-08 | 1994-12-13 | Ajinomoto Co Inc | Feed additive for ruminant |
| JPH0764547A (en) * | 1993-08-30 | 1995-03-10 | Roland Corp | Marker quantizer |
| JPH0787900A (en) * | 1993-09-27 | 1995-04-04 | Ajinomoto Co Inc | Feed additive composition for ruminant |
| GB9418752D0 (en) * | 1994-09-16 | 1994-11-02 | Ici Plc | Animal feedstuffs and additives |
| JPH08336360A (en) * | 1995-03-17 | 1996-12-24 | Kanagawa Kagaku Kenkyusho:Kk | Ruminant feed composition and feeding method using the same |
| US5807594A (en) * | 1997-02-26 | 1998-09-15 | Ducoa, L.P. | Method for enhancing feed efficiency in ruminants with an encapsulating choline composition |
| EP1381285B1 (en) * | 2001-04-16 | 2005-09-21 | Jubilant Organosys Limited | A rumen bypass composition containing a bioactive substance and a method for its preparation |
| DE10244397A1 (en) * | 2002-09-24 | 2004-04-01 | Basf Ag | Choline formulations |
| CN1561979A (en) * | 2004-04-21 | 2005-01-12 | 浙江大学 | Micro capsule for choline chloride for ruminant stomach and its preparing method |
-
2006
- 2006-05-02 KR KR1020060039733A patent/KR100698452B1/en active Active
- 2006-11-14 JP JP2009509394A patent/JP5159766B2/en active Active
- 2006-11-14 WO PCT/KR2006/004773 patent/WO2007126191A1/en not_active Ceased
- 2006-11-14 CN CN2006800544697A patent/CN101431903B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0163831B1 (en) * | 1995-03-18 | 1998-11-16 | 비비바흐, 카르그 | Method for preparing lysine protected against degradation in rumen and animal feed including the same |
| US6797291B2 (en) * | 2002-01-09 | 2004-09-28 | Balchem Corporation | Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101069118B1 (en) | 2008-10-22 | 2011-09-30 | 경상대학교산학협력단 | Method for preparing enteric choline chloride and choline chloride prepared according to the method |
| KR101219740B1 (en) | 2010-06-07 | 2013-01-11 | 대한민국 | Manufacturing method of Ruminally Protected Choline for high choline milk production And Ruminally Protected Choline Using Thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101431903A (en) | 2009-05-13 |
| JP5159766B2 (en) | 2013-03-13 |
| JP2009535056A (en) | 2009-10-01 |
| CN101431903B (en) | 2012-06-13 |
| WO2007126191A1 (en) | 2007-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100698452B1 (en) | Method of preparing ruminant protective choline | |
| JP7018239B2 (en) | Lumen Bypass Choline Chloride Microcapsules and Their Manufacturing Methods | |
| WO2005104868A1 (en) | Feed additive composition for ruminant, feed containing the same and process for producing feed additive composition for ruminant | |
| JP4908437B2 (en) | Feed additive for ruminant feeding to protect vitamin C, method for producing the same and use thereof | |
| ES2757844T3 (en) | Cashew Nut Oil with Enhanced Stability | |
| CN101626694B (en) | A product based on conjugated linoleic acid and a method for the manufacture thereof | |
| KR100869900B1 (en) | Double coated vitamin seeds and feed additives containing them | |
| KR101219740B1 (en) | Manufacturing method of Ruminally Protected Choline for high choline milk production And Ruminally Protected Choline Using Thereof | |
| CN101497456B (en) | Method for preparing acid catalysis air slaking B type copper chloride hydroxide and use | |
| EP3585362A1 (en) | Composition for controlled release of physiologically active substances and process for its preparation | |
| JP7423999B2 (en) | Feed composition, coated particles, method for producing feed composition | |
| CN119453375B (en) | A rumen-skimming coating preparation for ruminants and its preparation method and application | |
| FI85093C (en) | Feed and containing metal salt of fatty acid and process for its preparation | |
| CN114451497B (en) | Composition containing ethylenediamine dihydroiodine, and preparation method and application thereof | |
| RU2849605C1 (en) | Choline chloride-based fodder additive, protected from breakdown in paunch of ruminant animals | |
| CA3120429C (en) | Mineral supplements for ruminant nutrition | |
| US20220211076A1 (en) | Additive composition for ruminant feeds | |
| JPH1014500A (en) | Production of feed composition | |
| KR20250045326A (en) | Feed additive composition for improving high temperature stress in milking cows | |
| CN116725977A (en) | Rumen bypass lysine microcapsule rich in linolenic acid and preparation method thereof | |
| CN119054805A (en) | A preparation process of feed containing taurine and its product | |
| WO2021113982A1 (en) | Mineral supplements for ruminant nutrition | |
| CA2862398A1 (en) | A high energy rumen inert feedstuff | |
| PL113734B2 (en) | Method of obtaining a preparation capable to rise the contents of indispensable unsaturated fatty acids in the milk fat of ruminants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20060502 |
|
| PA0201 | Request for examination | ||
| A302 | Request for accelerated examination | ||
| PA0302 | Request for accelerated examination |
Patent event date: 20060718 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20060502 Patent event code: PA03021R01I Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20060830 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20070312 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20070315 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20070315 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20100226 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20110315 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20120315 Start annual number: 6 End annual number: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20130311 Year of fee payment: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20130311 Start annual number: 7 End annual number: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20140317 Year of fee payment: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20140317 Start annual number: 8 End annual number: 8 |
|
| FPAY | Annual fee payment |
Payment date: 20150313 Year of fee payment: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 20150313 Start annual number: 9 End annual number: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20160310 Year of fee payment: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20160310 Start annual number: 10 End annual number: 10 |
|
| FPAY | Annual fee payment |
Payment date: 20170310 Year of fee payment: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20170310 Start annual number: 11 End annual number: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20180309 Year of fee payment: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20180309 Start annual number: 12 End annual number: 12 |
|
| FPAY | Annual fee payment |
Payment date: 20200310 Year of fee payment: 14 |
|
| PR1001 | Payment of annual fee |
Payment date: 20200310 Start annual number: 14 End annual number: 14 |
|
| PR1001 | Payment of annual fee |
Payment date: 20220310 Start annual number: 16 End annual number: 16 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240308 Start annual number: 18 End annual number: 18 |
|
| PR1001 | Payment of annual fee |
Payment date: 20250310 Start annual number: 19 End annual number: 19 |